Aligos Therapeutics, Inc. · NASDAQ:ALGS

Woodline Partners LP reported a 8.70% stake in Aligos Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Woodline Partners LP reported a 8.70% stake in Aligos Therapeutics, Inc., 468,199 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
8.70%
Shares
468,199
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
Woodline Partners LP8.70%468,199

Source

View original at SEC

Related